Citius Pharmaceuticals Inc (CTXR) Stock Price Today
Key Stats
- $14.87MMarket Cap
- 154,710Volume
- HealthSector
- $1.8252W High
- $0.4852W Low
- 16 DaysTypical Hold Time
- $5.04MEnterprise Value
- -Div Yield
- 86% Sell | 14% BuyTrading Activity
Track Citius Pharmaceuticals Inc (CTXR) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Citius Pharmaceuticals Inc has traded between a low of $0.48 and a high of $1.82, highlighting its annual price range. Buy and sell Citius Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Most Recent News
Joby Aviation director sells shares amid eVTOL progress and financial challenges
A director at Joby Aviation sold 62,500 shares worth $380,625 while keeping a large stake. Joby is advancing its electric vertical take-off and landing (eVTOL) aircraft, aiming for passenger flights in Dubai by late 2026 pending FAA approval. Despite...

Shares of Nexalin, Integra LifeSciences, Western Digital, and Seagate plunge on operational and competition concerns.
On October 2, 2026, shares of Nexalin dropped 24.1% despite a new distribution deal, with no clear catalyst identified. Integra LifeSciences fell 21.2% after lowering its 2026 revenue outlook due to flooding disruptions. Western Digital and Seagate T...

Stablecoin Development and Armada Acquisition shares surge on key corporate moves and merger approval
On October 2, 2026, Stablecoin Development Corp. shares jumped 104.4%, trading above their 50-day moving average without a clear catalyst. Armada Acquisition Corp. II rose 68.2% following shareholder approval of its merger with Evernorth, expected to...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.